Диссертация (1140752), страница 17
Текст из файла (страница 17)
– Р.7–15.95.Johanna Laukkarinen, Juhani Sand, Isto Nordback. The Underlying Mechanisms:How Hypothyroidism Affects the Formation of Common Bile Duct Stones //Hindawi Publishing Corporation. – 2012. Article ID 10282596.Kiely J.M., Noh J.H., Graewin S. J., Pitt H.A., Swartz-Basile D.A. Alteredintestinal motility in leptin-deficient obese mice. J Surg Res 2005; 124:98-103.97.Koebnick C., Smith N., Black M.
Pediatric obesity and gallstone disease//J.Pediatric Gastroenterol. Nutr. – 2012. – Vol.55. – №3. – Р.328-333.98.Koivusalo A., Pakarinen M., Gylling H., Nissinen M. Relation of cholesterolmetabolism to pediatric gallstone disease: a retrospective controlled study//BMC Gastroenterol.
– 2015. – Vol.30. –№15. –P.74.99.Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markersof nonalcoholic fatty liver disease in patients with metabolic risk factors // Scand JGastroenterol. – 2012. – Vol. 47. – N 1. – Р.197-203.100.Kwak M.S., Kim D., Chung G.E., Kim Y.J., Yoon J.H. Cholecystectomyis independently associated with nonalcoholic fatty liver disease in an Asianpopulation //World J Gastroenterol. – 2015 . – V. –28. –№20. –Р.
6287-6295.101.Kim C, Herman WH, Vijan S. et ol. Efficacy and cost of postpartumscreening strategies for diabetes among women with histories of gestationaldiabetes mellitus // Diabetes Care. – 2007. –Vol.30. – №5. – P.1102–1106.102.Kurucsai G., Joó I., Fejes R. et al. Somatosensory hypersensitivity in thereferred pain area in patients with chronic biliary pain and a sphincter of Oddidysfunction: new aspects of an almost forgotten pathogenetic mechanism // Am. J.Gastroenterol. – 2008. – Vol.3 .– Р. 2717–2725.110103.Kushnareva NS, Smirnova OV. Changes in gender-related redistribution ofbilirubin pools in hyperprolactinemic rats during induction and relieving ofcholestasis// Bull Exp Biol Med.
– 2010. – Vol.149 .–№5. – Р.562-566.104.Le JA, Wilson HM, Shehu A, Devi YS, Aguilar T, Gibori G. Prolactinactivation of the long form of its cognate receptor causes increased visceral fat andobesity in males as shown in transgenic mice expressing only this receptorsubtype // Horm Metab Res. 201. –Vol.43.–№13. –P. 931-937.105.Leite NC et al. Prevalence and associated factors of non-alcoholic fattyliver disease in patients with type-2 diabetes mellitus // Liver Int.
– 2009. –№ 29.–Р.119.106.Lifang Hou, MD, PhD, Xiao-Ou Shu, MD, PhD, Yu-Tang Gao, MD et ol.Anthropometric Measurements, Physical Activity, and the Risk of SymptomaticGallstone Disease in Chinese Women // Ann Epidemiol. doi:10.1016/j.annepidem. – 2008.12.002107.Mansurov KhKh, Mirodzhov GK, Mansurova FKh, Dustov AD, MirzoevaPF, Mutikhova KhSh. Insulin resistance in patients with metabolic syndrome andcholelithiasis//Klin Med (Mosk). – 2005.
– Vol.83– №7–P.48-51.108.Mackillop L, Williamson C. Liver disease in pregnancy // Postgrad Med J.– 2010. –Vol.86–№1013. –P. 160–164.109.Maurer K., C. Carey, a Fox J.G. et ol. Roles of Infection, Inflammation,and the Immune System in Cholesterol Gallstone Formation// Gastroenterology. –2009. –Vol.136–№2. –P. 425–440.110.Mazaheri et al. Insulin resistance in hypothyroid patients underlevothyroxine therapy: a comparison between those with and without thyroidautoimmunity // Journal of Diabetes & Metabolic Disorders.
– 2014. – Vol. 13. –№1. –Р.103-110.111.McCollum P.T., Basso L., Darling M.R. et al. A descriptive study ofpregnant women with gallstones. Relation to dietary and social habits, education,physical activity, height and weight // Eur. J. Epidemiol. – 1992. – Vol. 8. – P.629–633.111112.Mechetina T.A., Bystrovskaia E.V., Il'chenko A.A. Rationale for theallocation of clinical variants of the postcholecystectomical syndrome associatedwith bacterial overgrowth in the small intestine//Eksp Klin Gastroenterol. – 2011.– №4 – P.37-43.113.McCulloough AJ.
Pathophysiology of non-alcoholic steatohepatitis // J.Clinical Gastroenterology. – 2006. –№ 40. –Р. 17-29.114.Mells J.E., Anania F.A. The Role of Gastrointestinal Hormones in HepaticLipid Metabolism // Semin Liver Dis. – 2013 . – Vol 3. – № 4. – Р.343-357.115.Moreno-Carranza Bibiana, Maite Goya-Arce, Claudia Vega et ol. Prolactinpromotes normal liver growth, survival, and regeneration in rodents:effects onhepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis // AmericanJournal of Physiology - Regulatory, Integrative and Comparative Physiology. –2013. – Vol.
305. – № 7. –P.720-R726. DOI: 10.1152/ajpregu.00282.2013116.Naim Ata, MD,1 Metin Kucukazman, MD,1 Bunyamin Yavuz. MD. et ol.The metabolic syndrome is associated with complicated gallstone disease// Can JGastroenterol. – 2011. – Vol. 25. – № 5. –P.274-276.117.Namburi RP, Karthik TS, Ponnala AR. Autoimmune hypothyroidismpresenting as pituitary hyperplasia // Indian J Pediatr. – 2014. – Vol. 81. – № 9. –P.937-939.118.Nahas EAP, Padoani NP, Nahas-Neto J, et al. Metabolic syndrome and itsassociated risk factors in Brazilian postmenopausal women // Climacteric.
– 2009.–№12. –Р.431–438.119.Nilsson M., Johnsen R., Ye W., Hveem K., Lagergren J. Obesity andestrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66-72.120.Nomura F., Ohnishi K., Satomura Y. et al. Liver function in moderateobesity: study in 534 moderately obese subjects among 4613 male companyemployees // Int J Obes. – 1986. – №10. – Р.349–354.121.Ong JP. Et al. epidemiology and natural history of NAFLD and NASH //Clin Liver disease. – 2007. – №11. – Р.1-16.112122.Pacifico L1, Chiesa C1, Anania C1, De Merulis A1, Osborn JF1,Romaggioli S1, Gaudio E1. Nonalcoholic fatty liver disease and the heart inchildren and adolescents.
World J Gastroenterol. – 2014. – Vol.20. –№ 27. –P.9055-71. doi: 10.3748/wjg.v20.i27.9055.123.Papathanasopoulos A., Camilleri M., Carlson P. J., Vella A., Nord S. J.,Burton D.D., Odunsi S. T., Zinsmeister A. R. A preliminary candidate genotypeintermediate phenotype study of satiation and gastric motor function in obesity.Obesity (Silver Spring) 2010; 18:1201- 11.124.Penta E, Lasalvia A. Delusion of pregnancy in a drug-naïve young womanshowing hyperprolactinemia and hypothyroidism: a case report //Gen HospPsychiatry. – 2013. – Vol. 35. –№6. – Р.679.125.Portincasa Р., Agostino Di Ciaula, Bonfrate L. , David QH Wang et ol.Therapy of gallstone disease: What it was, what it is, what it will be //World JGastrointest Pharmacol Ther. 2012. – 1992. – Vol.
3. –№2. – Р. 7–20.126.Plessis J., van Pelt J., Korf H. Association of Adipose Tissue InflammationWith Histological Severity of Non-alcoholic Fatty Liver Disease. – 2015. May 28.pii: S0016-5085(15)00771-4. doi: 10.1053/j.gastro.2015.05.044. [Epub ahead ofprint]127.Quallich L.G., Stern M.A., Rich M. et al. Bile duct crystals do not co–ntribute to sphincter of Oddi dysfunction // Gastrointest. Endosc. – 2002. – Vol. 2,N 55.– Р.163–166.128.Relationship of Non-alcoholic Fatty Liver Disease With Cholecystectomyin the US Population // Am J Gastroenterol. – 2013. –№ 108.
–Р. 952–958.129.Ress C, Maeser PA, Tschoner A, Loacker L. et ol. Serum prolactin inadvanced chronic liver disease// Horm Metab Res. – 2014– Vol. 46. –N 11. –Р.800–803.130.Reshetnyak V.I. Concept of the pathogenesis and treatment ofcholelithiasis//World J Hepatol. – 2012. – Vol. 4. – N2. – Р.18–34.113131.Rakoski M.O., Singal A.G., Rogers M.A. et al. Meta-analysis: insulinsensitizers for the treatment of non-alcoholic steatohepatitis // Aliment.Pharmacol. Ther. – 2010. – Vol. 32, N 10. – P.
1211–1221132.Ruhl C.E., Everhart JE. Relationship of non-alcoholic fatty liver diseasewith cholecystectomy in the US population // Am J Gastroenterol. – 2013. –Vol.108. – №6. – Р.952-958.133.Ruhl C.E., M.D., Ph.D. and James E. Everhart, M.D. Gallstone Disease isAssociated with Increased Mortality in the United States // Gastroenterology. –2011. – Vol.140. – №2. – Р.508–516.(Published online 2010 Nov 11. doi:10.1053/j.gastro.2010.10.060)134.Ruhl E.
et al. R. Byrne et al. NAFLD: a multisystem disease // Hepatology.– 2015. – №62. – Р.47-64.135.Sachdeva S., Khan Z., Ansari M Athar et ol. Lifestyle and GallstoneDisease: Scope for Primary Prevention// Indian J Community Med. –2011. –Vol.36. – №4. –P.
263–267.136.Sánchez-Cuén Jaime, Aguilar-Medina Maribel, Arámbula-Meraz Eliakymet ol. ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patientswith cholesterol gallstone disease // World J Gastroenterol. – 2010. – Vol.16. –№37. –P. 4685-4690.137.Seki E., Schnabl B. Role of innate immunity and the microbiota in liverfibrosis: crosstalk between the liver and gut. J Physiol 2012; 590:447-58138.Selvaggi F, Di Bartolomeo N, De Iuliis I, Del Ciotto N, Innocenti P.Laparoscopic treated so-called reformed gallbladder in patient withpostcholecystectomy chronic pain // G Chir.
– 2011. – Vol.32. – №6-7. – P. 335337.139.Selim G., Miraç Y.,D. Erdoğan. A retrospective review of children withgallstone: Single-center experience from Central Anatolia // Turk. J.Gastroenterol. – 2014. – Vol 25. –P. 46-53114140.Siddiqui M.S., Fuchs M., Idowu M. еt ol. Severity of nonalcoholic fattyliver disease and progression to cirrhosis are associated with atherogeniclipoprotein profile //Clin Gastroenterol Hepatol.
– 2015. – Vol. 13. – №5. –Р.1000-1008.141.Simon-Holtorf J, Mönig H, Klomp HJ, Reinecke-Lüthge A, Fölsch UR,Kloehn S. Expression and distribution of prolactin receptor in normal, fibrotic,and cirrhotic human liver// Exp Clin Endocrinol Diabetes. – 2006. – Vol.114. –№10. –P. 584-689142.Sharma N, Baliarsingh S, Kaushik GG. Biochemical association ofhyperprolactinemia with hypothyroidism in infertile women // Clin Lab.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
